Busca avançada
Ano de início
Entree


Long-Lasting, Fine-Tuned Anti-Tumor Activity of Recombinant Listeria monocytogenes Vaccine Is Controlled by Pyroptosis and Necroptosis Regulatory and Effector Molecules

Texto completo
Autor(es):
Olagunju, Abolaji S. ; Sardinha, Andrew V. D. ; Amarante-Mendes, Gustavo P.
Número total de Autores: 3
Tipo de documento: Artigo Científico
Fonte: PATHOGENS; v. 13, n. 10, p. 11-pg., 2024-10-01.
Resumo

One of the main objectives of developing new anti-cancer vaccine strategies is to effectively induce CD8+ T cell-mediated anti-tumor immunity. Live recombinant vectors, notably Listeria monocytogenes, have been shown to elicit a robust in vivo CD8+ T-cell response in preclinical settings. Significantly, it has been demonstrated that Listeria induces inflammatory/immunogenic cell death mechanisms such as pyroptosis and necroptosis in immune cells that favorably control immunological responses. Therefore, we postulated that the host's response to Listeria-based vectors and the subsequent induction of CD8+ T cell-mediated immunity would be compromised by the lack of regulatory or effector molecules involved in pyroptosis or necroptosis. To test our hypothesis, we used recombinant L. monocytogenes carrying the ovalbumin gene (LM.OVA) to vaccinate wild-type (WT), caspase-1/11-/-, gsdmd-/-, ripk3-/-, and mlkl-/- C57Bl/6 mice. We performed an in vivo cytotoxicity assay to assess the efficacy of OVA-specific CD8+ T lymphocytes in eliminating target cells in wild-type and genetically deficient backgrounds. Furthermore, we evaluated the specific anti-tumor immune response in mice inoculated with the B16F0 and B16F0.OVA melanoma cell lines. Our findings demonstrated that while caspase-1/11 and GSDMD deficiencies interfere with the rapid control of LM.OVA infection, neither of the KOs seems to contribute to the early activation of OVA-specific CTL responses. In contrast, the individual deficiency of each one of these proteins positively impacts the generation of long-lasting effector CD8+ T cells. (AU)

Processo FAPESP: 21/07624-6 - Papel dos mediadores de morte celular inflamatória na modulação da resposta imune anti-tumoral por Listeria monocytogenes
Beneficiário:Andrew Victor Diniz Sardinha
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 21/13486-5 - Papel de moléculas reguladoras da apoptose e de agentes desmetilantes de DNA na ativação e diferenciação de linfócitos T CD8
Beneficiário:João Gustavo Pessini Amarante Mendes
Modalidade de apoio: Auxílio à Pesquisa - Regular
Processo FAPESP: 21/12143-7 - Ativação in vivo, diferenciação e função efetora de células alvo específicas do antígeno por linfócitos T CD8+: papel da Caspase1, GSDMD, RIPK3 e MLKL
Beneficiário:Abolaji Samson Olagunju
Modalidade de apoio: Bolsas no Brasil - Doutorado
Processo FAPESP: 23/02577-5 - Estudo dos mecanismos responsáveis pela imunidade treinada induzida pelo Bacillus Calmette-Guérin (BCG) em doenças infecciosas e Câncer
Beneficiário:Sergio Costa Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Temático
Processo FAPESP: 18/25395-1 - Avaliação do papel de RASSF9 em melanoma através do sistema CRISPR/Cas9
Beneficiário:João Gustavo Pessini Amarante Mendes
Modalidade de apoio: Auxílio à Pesquisa - Regular